Cite
HARVARD Citation
Hampel, P. et al. (2022). Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia. British journal of haematology. pp. 239-244. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hampel, P. et al. (2022). Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia. British journal of haematology. pp. 239-244. [Online].